Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk van Lier

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Innate Immunity|June 25, 2026
In vivo cytokine adsorption reveals distinct neutrophil mobilization pathways during experimental human endotoxemiaSuzanne H Bongers, Bernard N Jukema, Aron Jansen, et al.
Frontiers in Medicine|December 19, 2022
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trialDirk van Lier, Adrien Picod, Gernot Marx, et al.
Mabs|May 21, 2026
Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3Magali Genest, Dirk Van Lier, Theo Ikenna Uba, et al.
Mabs|May 21, 2026
Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primatesDirk van Lier, Magali Genest, Adrien Picod, et al.
Intensive Care Medicine|August 26, 2024
Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patientsNiklas Bruse, Anna Motos, Rombout van Amstel, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Innate Immunity|June 25, 2026
In vivo cytokine adsorption reveals distinct neutrophil mobilization pathways during experimental human endotoxemiaSuzanne H Bongers, Bernard N Jukema, Aron Jansen, et al.
Frontiers in Medicine|December 19, 2022
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trialDirk van Lier, Adrien Picod, Gernot Marx, et al.
Mabs|May 21, 2026
Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3Magali Genest, Dirk Van Lier, Theo Ikenna Uba, et al.
Mabs|May 21, 2026
Preclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primatesDirk van Lier, Magali Genest, Adrien Picod, et al.
Intensive Care Medicine|August 26, 2024
Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patientsNiklas Bruse, Anna Motos, Rombout van Amstel, et al.
Pageof 2